The rapid evolution of modern biotechnology has enabled scientists to modify the genetic structures of living organisms, introducing traits like pest resistance and drought tolerance. However, these innovations present potential ecological risks. If released into nature unchecked, these altered organisms could outcompete native species, disrupt food webs, and cause irreversible genetic contamination.
Defining the Cartagena Protocol on Biosafety
The Cartagena Protocol on Biosafety is a supplementary agreement to the Convention on Biological Diversity (CBD). It is a legally binding international framework designed to ensure the safe transfer, handling, and use of living modified organisms resulting from modern biotechnology, specifically focusing on transboundary movements.
Background and Objectives
- The Genesis: The treaty was adopted on January 29, 2000, in Montreal, Canada (after initial negotiations in Cartagena, Colombia), and formally entered into force on September 11, 2003.
- Core Philosophy: It is deeply rooted in the Precautionary Principle, which states that a lack of full scientific certainty regarding potential harm should not prevent nations from taking protective measures to limit the import of modified organisms.
Primary Objectives:
- To protect global biological diversity from the potential risks posed by modern biotechnology.
- To establish a transparent, predictable regulatory system for the international transfer of altered biological agents.
- To ensure human health is not compromised by the introduction of genetic innovations into food systems.
Scope of the Protocol: Navigating LMOs and GMOs UPSC Core Concepts
To write precise answers, candidates must master how the protocol handles modified lifeforms:
- Living Modified Organisms (LMOs): Any living organism that possesses a novel combination of genetic material obtained through the use of modern biotechnology (e.g., live GM seeds, live bio-engineered fish). The protocol primarily focuses on LMOs because they can reproduce and spread their modified genes in the wild.
- Genetically Modified Organisms (GMOs): A broader umbrella term covering all genetically altered entities. This includes processed, non-living products derived from genetic engineering (e.g., processed corn oil or soybean flour).
Key Distinction: While all LMOs are GMOs, non-living products like processed GM foods are generally excluded from the strict transboundary advance notification rules of the protocol because they cannot replicate in natural ecosystems.
Key Features of the Cartagena Protocol
The protocol enforces safety through three major operational mechanisms:
A. Advance Informed Agreement (AIA) Procedure
The AIA is the cornerstone of the treaty. It mandates that before an exporting nation can ship an LMO intended for intentional introduction into the environment (such as seeds for cultivation) for the first time, it must give formal advance notice to the importing nation. The importing country then has the legal right to conduct a rigorous risk assessment before granting or denying permission.
B. LMOs intended for Food, Feed, or Processing (LMOs-FFP)
For LMOs intended for direct use as food, feed, or processing rather than introduction into the environment (e.g., GM commodities like bulk corn shipments), nations must log their approvals into a centralized international database within 15 days of domestic clearance.
C. The Biosafety Clearing-House (BCH)
The BCH is an online knowledge platform established by the protocol. It acts as a transparent global ledger where countries must share scientific information, environmental risk assessments, national biosafety laws, and final import declarations.
India and the Cartagena Protocol
India is a party to the protocol, having ratified it in 2003. Domestically, India implements its biosafety mandates through a comprehensive legal structure:
- Statutory Framework: Implemented via the Rules for the Manufacture, Use, Import, Export and Storage of Hazardous Microorganisms, Genetically Engineered Organisms or Cells, 1989, framed under the Environment (Protection) Act, 1986.
- Apex Regulatory Body: The Genetic Engineering Appraisal Committee (GEAC) under the Ministry of Environment, Forest and Climate Change (MoEFCC) is the apex statutory authority that reviews and approves the environmental release and import of all LMOs.
- Institutional Node: The Ministry of Environment serves as India’s official National Focal Point for managing the international Biosafety Clearing-House.
Cartagena Protocol vs. Nagoya Protocol
Candidates frequently confuse these two supplementary agreements of the CBD. They target entirely distinct ecological challenges:
| Feature | Cartagena Protocol | Nagoya Protocol |
| Primary Focus | Biosafety and containment of genetic hazards. | Access and Benefit Sharing (ABS) of genetic resources. |
| Core Target | Regulating the safe transboundary movement of LMOs and GMOs. | Preventing Biopiracy of traditional indigenous knowledge. |
| Key Metric | Risk assessment and Advance Informed Agreement (AIA). | Prior Informed Consent (PIC) and Mutually Agreed Terms (MAT). |
Implementation Challenges and Conclusion
The protocol faces structural hurdles, such as the fact that major GMO-producing nations like the United States are not parties to the treaty. Additionally, many developing nations lack the advanced laboratory infrastructure and specialized personnel needed to conduct rigorous molecular risk assessments at their customs borders.
In conclusion, for a high-scoring strategy in the Cartagena Protocol UPSC segment, candidates must view the treaty as a shield for global biosecurity. Reversing biodiversity loss requires that modern genetic innovations are managed safely. Enforcing the Cartagena framework ensures that humanity can utilize biotechnology to build climate-resilient food supplies without compromising the integrity of Earth’s natural ecosystems.
UPSC Prelims: PYQs & Practice Questions
Previous Year Questions (Prelims)
UPSC CSE Prelims 2011
Q: Consider the following statements:
1. The Cartagena Protocol on Biosafety is an international treaty governing the movements of
living modified organisms (LMOs) resulting from modern biotechnology from one country to another.
2. The Nagoya Protocol on Access and Benefit Sharing is a supplementary agreement to the
Convention on Biological Diversity (CBD).
Which of the statements given above is/are correct?
(a) 1 only
(b) 2 only
(c) Both 1 and 2
(d) Neither 1 nor 2
Answer: (c) Both 1 and 2
Explanation:
Both statements are correct. The
Cartagena Protocol on Biosafety, adopted in 2000, and the
Nagoya Protocol, adopted in 2010, are two important supplementary protocols under the parent
Convention on Biological Diversity (CBD).
The Cartagena Protocol focuses on minimizing biosafety risks from the transboundary movement of LMOs. The Nagoya Protocol deals with Access and Benefit Sharing (ABS) and helps prevent biopiracy by ensuring fair sharing of benefits arising from genetic resources.
UPSC CSE Prelims 2018
Q: With reference to the Genetic Engineering Appraisal Committee (GEAC), consider the following statements:
1. It is established under the Biological Diversity Act, 2002.
2. It functions under the Ministry of Environment, Forest and Climate Change.
3. It is the apex body that accords approval for appraisal of proposals relating to release of genetically engineered organisms and products into the environment.
Which of the statements given above are correct?
(a) 1 and 2 only
(b) 2 and 3 only
(c) 1 and 3 only
(d) 1, 2 and 3
Answer: (b) 2 and 3 only
Explanation:
Statement 1 is incorrect. The GEAC is not established under the
Biological Diversity Act, 2002. It functions under the framework of the
Environment (Protection) Act, 1986, especially through the rules notified in 1989 for genetically engineered organisms.
Statements 2 and 3 are correct. The GEAC functions under the Ministry of Environment, Forest and Climate Change (MoEFCC). It is India’s apex regulatory body for approving proposals related to environmental release, field trials, commercial cultivation, import, and use of genetically engineered organisms and their products.
Practice Questions
Q: In the context of international biosafety trade standards regulated under the Cartagena Protocol, consider the following statements regarding the Advance Informed Agreement (AIA) procedure:
1. The AIA procedure is mandatory for all transboundary movements of
Living Modified Organisms (LMOs), including those explicitly destined for direct use as food, feed, or for processing
(LMOs-FFP).
2. It legally empowers an importing nation to block incoming shipments of an LMO based on the
Precautionary Principle, even if there is a temporary lack of full scientific certainty regarding its long-term ecological risks.
Which of the statements given above is/are correct?
(a) 1 only
(b) 2 only
(c) Both 1 and 2
(d) Neither 1 nor 2
Answer: (b) 2 only
Explanation:
Statement 1 is incorrect. The strict
Advance Informed Agreement (AIA) procedure does not apply to all LMOs. It specifically excludes
LMOs intended for direct use as food, feed, or processing (LMOs-FFP), such as bulk GM corn or soybean shipments meant for consumption or processing rather than planting.
Statement 2 is correct. The Cartagena Protocol is rooted in the Precautionary Principle. It allows an importing country to restrict or block the import of an LMO if there is a possibility of ecological risk, even when complete scientific certainty is not yet available.
Q: Which of the following digital platforms serves as the official international ledger established by the Cartagena Protocol to facilitate the exchange of scientific, technical, environmental, and legal information on living modified organisms?
(a) The Access and Benefit-Sharing Clearing-House (ABS-CH)
(b) The Biosafety Clearing-House (BCH)
(c) The Global Environmental Facility Portal (GEF-P)
(d) The CITES Trade Database
Answer: (b) The Biosafety Clearing-House (BCH)
Explanation:
The Biosafety Clearing-House (BCH) is the centralized online information platform established under
Article 20 of the Cartagena Protocol.
It enables member countries to share their national biosafety laws, risk assessments, import decisions, scientific data, and regulatory information related to Living Modified Organisms (LMOs). This ensures transparency and cooperation in global biosafety governance.
UPSC Mains – Previous Year & Practice Questions
Mains Previous Year Questions
Mains 2023
Question: Identify the main causes of the loss of
biodiversity in India.
(Requires explaining how accidental genetic contamination from unregulated LMOs can threaten indigenous crop relatives.)
Mains 2018
Question: How does biodiversity vary in India?
How is the Biological Diversity Act, 2002 helpful in conservation of flora and fauna?
(Tests how domestic laws complement global CBD frameworks like Cartagena to protect indigenous bio-resources.)
Mains 2019
Question: What can India learn from
solar energy harvest to improve its renewable energy target?
(Can contrast industrial growth with the stringent biosafety regulations applied to agricultural biotechnology.)
Mains 2015
Question: What are the main bottlenecks in the adoption of
genetically modified (GM) crops in India?
(Directly links to India's domestic enforcement of Cartagena Protocol principles through GEAC guidelines.)
Mains 2020
Question: How does the draft
Environment Impact Assessment (EIA) Notification differ from the existing
EIA Notification, 2006?
(Useful for connecting environmental clearance debates with biosafety, precautionary regulation, and ecological risk assessment.)
Mains Practice Questions
[10 Marks | 150 Words]
Question: Differentiate between Living Modified Organisms (LMOs) and Genetically Modified Organisms (GMOs) under international law. Explain why the Cartagena Protocol prioritizes the regulation of the former over the latter.
[15 Marks | 250 Words]
Question: Analyze the statutory framework governing biosafety clearances in India. To what extent does the Genetic Engineering Appraisal Committee (GEAC) satisfy India’s international commitments under the Cartagena Protocol on Biosafety?
[15 Marks | 250 Words]
Question: The Precautionary Principle balances economic scientific innovation with ecological security. Discuss how this principle is operationalized through the Advance Informed Agreement (AIA) mechanism of the Cartagena Protocol.
Cartagena Protocol-FAQs
Why does Cartagena Protocol focus on LMOs, not GMOs?
It focuses on Living Modified Organisms because they are alive and can reproduce or transfer modified genes in nature. Processed GMO products like oil or cotton fabric cannot spread genes, so they pose less direct biodiversity risk.
What is Advance Informed Agreement?
AIA requires an exporter to get written permission from the importing country before first-time environmental release of an LMO. It allows the importer to assess risks before approval.
Does AIA apply to GM food or grain imports?
No. LMOs meant for food, feed, or processing follow a simpler system through the Biosafety Clearing-House. Countries can check safety data and decide import rules.
What if scientific certainty is lacking?
Under the Precautionary Principle, a country can restrict or reject an LMO import even without full scientific certainty. Suspected risk to biodiversity or health is enough for caution.
